Biotechnology in Belgium

Date: February 12, 2015
Pages: 38
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B837D129BC7EN
Leaflet:

Download PDF Leaflet

Biotechnology in Belgium
INTRODUCTION

Biotechnology in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Belgium biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

HIGHLIGHTS
  • The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
  • The Belgian biotechnology industry had total revenues of $7.8bn in 2014, representing a compound annual growth rate (CAGR) of 7% between 2010 and 2014.
  • The medical/healthcare segment was the industry's most lucrative in 2014, with total revenues of $6.0bn, equivalent to 76.4% of the industry's overall value.
  • The performance of the industry is forecast to accelerate, with an anticipated CAGR of 8.8% for the five-year period 2014 - 2019, which is expected to drive the industry to a value of $11.9bn by the end of 2019.
FEATURES
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in Belgium
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Belgium
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Belgium biotechnology market with five year forecasts
  • Macroeconomic indicators provide insight into general trends within the Belgium economy
KEY QUESTIONS ANSWERED
  • What was the size of the Belgium biotechnology market by value in 2014?
  • What will be the size of the Belgium biotechnology market in 2019?
  • What factors are affecting the strength of competition in the Belgium biotechnology market?
  • How has the market performed over the last five years?
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
AstraZeneca PLC
Novartis AG
Sanofi SA
ThromboGenics NV
Macroeconomic Indicators
Country Data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table: Belgium biotechnology industry value: $ billion(e)
Table: Belgium biotechnology industry category segmentation: $ billion, (e)
Table: Belgium biotechnology industry geography segmentation: $ billion, (e)
Table: Belgium biotechnology industry value forecast: $ billion
Table: AstraZeneca PLC: key facts
Table: AstraZeneca PLC: key financials ($)
Table: AstraZeneca PLC: key financial ratios
Table: Novartis AG: key facts
Table: Novartis AG: key financials ($)
Table: Novartis AG: key financial ratios
Table: Sanofi SA: key facts
Table: Sanofi SA: key financials ($)
Table: Sanofi SA: key financials (€)
Table: Sanofi SA: key financial ratios
Table: ThromboGenics NV: key facts
Table: ThromboGenics NV: key financials ($)
Table: ThromboGenics NV: key financials (€)
Table: ThromboGenics NV: key financial ratios
Table: Belgium size of population (million)
Table: Belgium gdp (constant prices, $ billion)
Table: Belgium gdp (current prices, $ billion)
Table: Belgium inflation
Table: Belgium consumer price index (absolute)
Table: Belgium exchange rate

LIST OF FIGURES

Figure: Belgium biotechnology industry value: $ billion(e)
Figure: Belgium biotechnology industry category segmentation: % share, by value, (e)
Figure: Belgium biotechnology industry geography segmentation: % share, by value, (e)
Figure: Belgium biotechnology industry value forecast: $ billion
Figure: Forces driving competition in the biotechnology industry in Belgium,
Figure: Drivers of buyer power in the biotechnology industry in Belgium,
Figure: Drivers of supplier power in the biotechnology industry in Belgium,
Figure: Factors influencing the likelihood of new entrants in the biotechnology industry in Belgium,
Figure: Factors influencing the threat of substitutes in the biotechnology industry in Belgium,
Figure: Drivers of degree of rivalry in the biotechnology industry in Belgium,
Figure: AstraZeneca PLC: revenues & profitability
Figure: AstraZeneca PLC: assets & liabilities
Figure: Novartis AG: revenues & profitability
Figure: Novartis AG: assets & liabilities
Figure: Sanofi SA: revenues & profitability
Figure: Sanofi SA: assets & liabilities
Figure: ThromboGenics NV: revenues & profitability
Figure: ThromboGenics NV: assets & liabilities

Skip to top


Ask Your Question

Biotechnology in Belgium
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: